New Delhi: Corona vaccine maker Serum Institute of India (SII) and a government official said on Tuesday that India is struggling to export the remaining doses in addition to the corona vaccine. The vaccines have been produced more than india's programme, but the company has no other demand. He said that even after low levels of vaccination in many countries, there are management hurdles in their use.
Serum Institute, the world's largest vaccine maker, has already announced a temporary halved production of astrazeneca (covishield) drug until a major order arrives. "Some countries have immunized only 10 or 15 per cent of their population, while they should have immunized 60-70 per cent of the population so far," adar Poonawala, CEO of SII, said at a virtual conference organized by the Confederation of Indian Industry. The demand is very high there, but there is a publicity that the supply has exceeded the monthly demand. '
Top Indian health officer Vinod Kumar Paul told the conference that the current global production of corona vaccine was to be around 36 lakh doses, which has not yet taken place. He further said that India is in a position to supply vaccine, but is there a demand from anywhere? He said the idea should be on how to speed up supply. How to increase its use in many countries, especially in the African continent. Africa's disease control body said many of its countries were facing vaccine management problems late last month as the vaccine suddenly increased after months of delay.
COVID-19 vaccination coverage in India has surpassed 134.61 cr
India-Pakistan to Clash on 6 march in World Cup, ICC releases schedule
LPG gas cylinder also has an expiry date, find out how to identify